Panacea in vaccine deal with Philippine firm

Panacea Biotec has entered into a memorandum of agreement (MoA) with Family Vaccines, Philippines to provide value added combination vaccines to the people in Philippines through a chain of 50 immunisation clinics, run by Family Vaccines.

According to an official release issued by Panacea to the BSE today, it has been playing an imperative role in immunisation through its novel and innovative, world's first fully liquid vaccine with brands such as, 'Easy Four' & 'Easy Five', for over 3 years. It has partnered with. WHO & UNICEF with a mission of supporting the cause of maximising coverage of vaccines under the Expanded Program on Immunisation (EPI) for mote than a decade.

Speaking on the occasion, Rajesh Jain, JMD, Panacea Biotec said: "Panacea Biotec has built an innovative portfolio in combination vaccines under 'Easy' range of vaccines which has enabled it achieve a leadership position in just about two years of its launch in India. While fully liquid DTP combos would be the arena of focus to start the partnership with Family Vaccine, it would eventually work towards introduction of Polprotec (IPV) and its combination vaccines in due course. With a very strong, innovative product pipeline in immunisation, Panacea Biotec is all set to venture into global markets."

The MoA was signed between Rajesh Jain, JMD, Panacea Biotec and Jaime Enrique Gonzalez, MD, Family Vaccines on the platform of Confederation of Indian Industries (CII) in Mumbai on October 04, 2007.